On August 26, pharmaceutical manufacturer Indivior announced that it had begun supplying the Biomedical Advanced Research and Development Authority (BARDA)…
On August 7 the Food and Drug Administration approved an opioid overdose antidote developed by Purdue Pharma that contains nalmefene,…
Opvee, an opioid-overdose antidote manufactured by Indivior that was approved in 2023, has in recent weeks been slowly rolling out…